Psychiatry and Neurology, Neurology · North Haven, CT
NPI
1639495559
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6 Devine St, Suite 2b
North Haven, CT, 06473
Phone (203) 287-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
228 services
Medicare patients, 2024
138
Average age 67
Drug cost, 2024
$1.3M
577 prescriptions
Company payments, 2025
$48.33
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katherine A Destefano was code 99214 (office e&m - established), 117 times for 87 patients. In total Katherine A Destefano billed 228 services in 12 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 117 | 87 | $76.45 | $8,944 |
| 99215 Office E&M - Established | Office | 62 | 53 | $109.24 | $6,773 |
| 99222 Hospital E&M - Initial | Facility | 15 | 14 | $106.82 | $1,602 |
| 99213 Office E&M - Established | Office | 12 | 12 | $54.76 | $657 |
By year: 2022 $18K for 192 services; 2023 $20K for 217 services; 2024 $20K for 228 services.
Medicare prescription drug claims, 2024
In 2024, the drug Katherine A Destefano prescribed most often to Medicare patients was Baclofen, with 111 prescriptions and refills. In total Katherine A Destefano wrote 577 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 111 | 171 | 28 | $2,166 |
| Dalfampridine Er Dalfampridine | 86 | 94 | 11 | $35K |
| Gabapentin Generic | 68 | 96 | 15 | $1,650 |
| Glatiramer Acetate Generic | 56 | 56 | Under 11 | $105K |
| Tecfidera Dimethyl Fumarate | 51 | 51 | Under 11 | $449K |
| Tizanidine Hcl Generic | 30 | 47 | Under 11 | $307 |
| Fingolimod Fingolimod Hcl | 28 | 28 | Under 11 | $5,920 |
| Copaxone Glatiramer Acetate | 27 | 27 | Under 11 | $155K |
| Dimethyl Fumarate Generic | 22 | 22 | Under 11 | $34K |
| Kesimpta Pen Ofatumumab | 21 | 21 | Under 11 | $169K |
| Avonex (4 Pack) Interferon Beta-1a | 12 | 12 | Under 11 | $97K |
| Avonex Pen (4 Pack) Interferon Beta-1a | 12 | 12 | Under 11 | $97K |
| Teriflunomide Generic | 11 | 11 | Under 11 | $457 |
Brand drugs: 143 claims; generic drugs: 434 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katherine A Destefano $48.33 ($48.33 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $48.33.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $48.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.